Health
newsGP – Novavax confirms efficacy against emerging coronavirus variants – RACGP
New data on Australia’s third vaccine candidate shows it is highly effective against most COVID-19 variants, which may prove crucial as production bottlenecks force…
News
New data on Australia’s third vaccine candidate shows it is highly effective against most COVID-19 variants, which may prove crucial as production bottlenecks force delays among other options.
Interim results Novavaxs phase 3 clinical trials show it has 95.6% efficacy against the main COVID strain.
The interim results from one arm of Novavax’s phase 3 clinical trials show it has 95.6% efficacy against the main coronavirus strain – and is almost as effective against the concerning UK variant,…
-
General13 hours agoPolice investigating after body found on road in Newborough, Gippsland
-
Noosa News17 hours agoNew One Nation branch | Noosa Today
-
General9 hours agoGeelong Cats fined by AFL over third-party arrangements
-
Noosa News7 hours agoFederal government to review trade restrictions for Philippine banana imports